MedPath

An observational study examining endothelium-dependent vasodilatation before and after high-dose rosuvastatin therapy

Not Applicable
Conditions
Hyperlipidemia
Registration Number
JPRN-UMIN000006029
Lead Sponsor
Osaka City University Graduate School of Medicine Department of Internal medicine and Cardiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with familiar hyperlipidemia 2) Patients with rosuvastatin hypersensitivity 3) Patients with abnormal values of laboratory tests 4) Patients with kidney transplantation or dialysis 5) Patients with administration of cyclosporine 6) Pregnant women, or nursing women 7) Patients with history of hypothyroidism, hereditary myopathy, drug-induced muscle disorder or family history of hereditary myopathy 8) Patients with drug abuse, or alcoholism 9) Patients with malignant disease

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endothelium-dependent vasodilatation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath